Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.65
Percentage change -4.56	%

Peers: DXCM PODD TNDM ABT MDT LCTX VTRS BAX BMY MRK

| Held by: IJR VTI VB IWM VBR VXF IJS SPSM IWN VIG

Index	RUT	P/E	13.60	EPS (ttm)	1.01	Insider Own	7.95%	Shs Outstand	58.13M	Perf Week	5.13%
Market Cap	794.55M	Forward P/E	4.53	EPS next Y	3.02	Insider Trans	0.21%	Shs Float	53.51M	Perf Month	-21.88%
Income	58.20M	PEG	1.46	EPS next Q	0.53	Inst Own	90.02%	Short Float	4.16%	Perf Quarter	-28.96%
Sales	1.11B	P/S	0.72	EPS this Y	14.73%	Inst Trans	0.93%	Short Ratio	4.56	Perf Half Y	-10.79%
Book/sh	-13.23	P/B	-	EPS next Y	7.39%	ROA	4.92%	Short Interest	2.23M	Perf Year	-0.75%
Cash/sh	3.73	P/C	3.67	EPS next 5Y	9.34%	ROE	-	52W Range	9.93 - 21.48	Perf YTD	-33.81%
Dividend Est.	0.61 (4.43%)	P/FCF	27.49	EPS past 5Y	-	ROI	7.22%	52W High	-36.37%	Beta	1.08
Dividend TTM	0.60 (4.39%)	Quick Ratio	1.67	Sales past 5Y	0.32%	Gross Margin	63.01%	52W Low	37.71%	ATR (14)	0.85
Dividend Ex-Date	Feb 28, 2025	Current Ratio	2.24	EPS Y/Y TTM	4.59%	Oper. Margin	23.63%	RSI (14)	39.94	Volatility	6.59% 5.83%
Employees	2100	Debt/Eq	-	Sales Y/Y TTM	-1.31%	Profit Margin	5.25%	Recom	2.75	Target Price	22.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-100.00%	Payout	44.70%	Rel Volume	1.24	Prev Close	14.32
Sales Surprise	1.90%	EPS Surprise	31.77%	Sales Q/Q	-5.55%	Earnings	Feb 06 BMO	Avg Volume	488.81K	Price	13.67
SMA20	-2.66%	SMA50	-19.97%	SMA200	-11.47%	Trades		Volume	234,715	Change	-4.56%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$13 → $20
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy	$26
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Feb-19-25 03:36PM	Embecta Corp. (EMBC): Among Last Weeks Worst Dividend Stocks (Insider Monkey)
Feb-18-25 05:00PM	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire)
Feb-07-25 02:09AM	Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Feb-06-25 07:45AM	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
06:00AM	Loading…
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jan-23-25 05:00PM	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire)
Dec-19-24 05:00PM	embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-09-24 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) (Zacks)
Dec-06-24 06:00AM	Embecta to cut 125 jobs after ending insulin patch pump (MedTech Dive)
Nov-27-24 06:40AM	Embecta to discontinue insulin patch pump program, initiates restructuring plan (TipRanks) +10.11%
02:02AM	Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance (GuruFocus.com)
12:26AM	Q4 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-26-24 01:15PM	Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps (Benzinga) +29.77%
07:40AM	Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates (Zacks)
06:40AM	Loading…
06:40AM	Embecta discontinues insulin patch pump development (MedTech Dive)
06:30AM	Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
Nov-12-24 05:31PM	UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell (GlobeNewswire) -6.37%
Sep-03-24 07:55AM	Embecta gets FDA nod for insulin patch pump (MedTech Dive)
06:30AM	embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes (GlobeNewswire)
Aug-22-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire) +6.14%
Aug-12-24 09:35AM	Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average (Zacks)
Aug-10-24 08:18AM	Embecta Corp. (NASDAQ:EMBC) Q3 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 (InvestorPlace) +7.32%
07:40AM	Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:30AM	Loading…
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Aug-02-24 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline (Zacks)
Jul-31-24 09:47AM	Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock? (Zacks)
Jul-29-24 08:05AM	Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company (PR Newswire)
Jul-24-24 04:21AM	Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Jul-22-24 07:42AM	Diabetes device firm Embecta considers sale: Financial Times (MedTech Dive) +15.26%
Jul-18-24 05:00PM	embecta to Report Fiscal Third Quarter 2024 Financial Results (GlobeNewswire)
Jun-25-24 07:47AM	Embecta touts its insulin patch pump at ADA (MedTech Dive)
Jun-24-24 06:30AM	embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir (GlobeNewswire)
Jun-20-24 07:30AM	Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors (PR Newswire)
May-21-24 04:30PM	Trade Winds Turning: 3 Stocks Poised to Gain from Biden's China Tariffs (InvestorPlace)
May-13-24 11:52AM	Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 02:12PM	Embecta Corp (EMBC) Surpasses Analyst Revenue Forecasts in Q2 Fiscal 2024 (GuruFocus.com)
May-09-24 10:54AM	EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +37.88%
06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-24 05:00PM	embecta to Participate in Investor Events (GlobeNewswire)
Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 10:07PM	Q1 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents) -8.47% -7.91%
11:43AM	Why Embecta Stock Is Tanking Today (Motley Fool)
07:45AM	Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:07AM	Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-07-24 05:00PM	embecta to Participate in the 11th Annual BTIG MedTech Conference (GlobeNewswire)
Jan-24-24 05:00PM	embecta to Report Fiscal First Quarter 2024 Financial Results (GlobeNewswire)
Jan-21-24 08:33AM	16 Most Profitable New Stocks Today (Insider Monkey)
Jan-09-24 06:00AM	embecta Announces FDA 510(k) Submission for Insulin Patch Pump (GlobeNewswire)
Dec-14-23 05:00PM	embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-01-23 06:00AM	No embecta-made syringes impacted by FDA safety communication (GlobeNewswire)
05:13AM	Embecta Corp's Dividend Analysis (GuruFocus.com)
Nov-29-23 05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
Nov-22-23 09:34AM	Embecta Corp. (NASDAQ:EMBC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-21-23 07:23AM	Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s (MedTech Dive)
07:15AM	Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Embecta Corp (EMBC) Posts Mixed Fiscal 2023 Results and Issues Fiscal 2024 Guidance (GuruFocus.com)
05:30AM	Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance (GlobeNewswire)
05:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-14-23 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q4 Earnings Expected to Decline (Zacks) +7.29%
Oct-31-23 06:50AM	embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell (GlobeNewswire)
Oct-25-23 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) -9.02%
Sep-28-23 08:10PM	7 Contrarian Stocks to Buy for the High-Stakes Gambler (InvestorPlace)
Sep-06-23 05:00PM	embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference (GlobeNewswire) -13.20%
Aug-11-23 06:08AM	Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15 (Simply Wall St.)
Aug-08-23 10:19PM	Q3 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-11-23 05:00PM	embecta to Report Fiscal Third Quarter 2023 Financial Results (GlobeNewswire)
Jun-30-23 06:15AM	The Market Doesn't Like What It Sees From Embecta Corp.'s (NASDAQ:EMBC) Revenues Yet (Simply Wall St.)
Jun-21-23 08:00PM	EMBC: Lowering target price to $26.00 (Argus Research)
May-20-23 08:26AM	Just Four Days Till Embecta Corp. (NASDAQ:EMBC) Will Be Trading Ex-Dividend (Simply Wall St.)
May-15-23 05:38PM	UPDATE -- embecta to Participate in Investor Conferences (GlobeNewswire) -6.45%
05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
09:30AM	Embecta Corp. (EMBC) Recently Broke Out Above the 50-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
May-13-23 08:16AM	Embecta Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
12:05AM	Q2 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
May-12-23 06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire) +6.12%
06:15AM	embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-23 01:08PM	Embecta (EMBC) to Report Q2 Earnings: What's in Store? (Zacks)
Apr-26-23 08:00PM	EMBC: Lowering target price to $29.00 (Argus Research)
Apr-22-23 07:20AM	3 Top Dividend Kings to Buy for the Long Haul (Motley Fool)
Apr-21-23 06:15PM	Embecta Corp. (EMBC) Outpaces Stock Market Gains: What You Should Know (Zacks)
Apr-20-23 05:00PM	embecta to Report Fiscal Second Quarter 2023 Financial Results (GlobeNewswire)
Mar-26-23 08:45AM	3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential (Motley Fool)
Mar-22-23 06:46AM	Investors in Embecta (NASDAQ:EMBC) from a year ago are still down 25%, even after 3.5% gain this past week (Simply Wall St.) -5.70%

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	Feb 25 '25	Buy	13.67	13,000	177,646	76,681	Feb 25 04:26 PM
Morris Milton Mayo	Director	Feb 13 '25	Sale	16.38	3,100	50,783	36,133	Feb 14 06:42 PM
Morris Milton Mayo	Director	Feb 13 '25	Proposed Sale	16.38	3,100	50,778		Feb 13 03:57 PM

Open in Screener

MYO

Myomo Inc

Mar 12 • 11:48AM ET

5.53

Dollar change -0.34
Percentage change -5.79	%

Healthcare • Medical Devices • USA • AMEX

Peers: ZBH INSP TNDM OFIX SRDX RCEL SIBN ATEC BLFS STXS

Index	-	P/E	-	EPS (ttm)	-0.17	Insider Own	6.65%	Shs Outstand	34.38M	Perf Week	18.16%
Market Cap	183.85M	Forward P/E	1660.66	EPS next Y	0.00	Insider Trans	0.00%	Shs Float	31.04M	Perf Month	-8.60%
Income	-6.18M	PEG	-	EPS next Q	-0.08	Inst Own	52.66%	Short Float	2.47%	Perf Quarter	-8.14%
Sales	32.55M	P/S	5.65	EPS this Y	9.38%	Inst Trans	50.20%	Short Ratio	1.76	Perf Half Y	38.25%
Book/sh	0.72	P/B	7.69	EPS next Y	102.30%	ROA	-21.76%	Short Interest	0.77M	Perf Year	73.35%
Cash/sh	0.75	P/C	7.39	EPS next 5Y	-	ROE	-36.69%	52W Range	2.51 - 7.17	Perf YTD	-14.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	62.04%	ROI	-19.28%	52W High	-22.87%	Beta	1.42
Dividend TTM	-	Quick Ratio	2.91	Sales past 5Y	57.09%	Gross Margin	71.23%	52W Low	120.25%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	3.22	EPS Y/Y TTM	39.01%	Oper. Margin	-19.07%	RSI (14)	52.03	Volatility	9.46% 6.47%
Employees	185	Debt/Eq	0.33	Sales Y/Y TTM	69.17%	Profit Margin	-19.00%	Recom	1.00	Target Price	8.81
Option/Short	Yes / Yes	LT Debt/Eq	0.30	EPS Q/Q	90.41%	Payout	-	Rel Volume	2.79	Prev Close	5.87
Sales Surprise	21.93%	EPS Surprise	57.08%	Sales Q/Q	153.73%	Earnings	Mar 10 AMC	Avg Volume	435.41K	Price	5.53
SMA20	3.50%	SMA50	-5.69%	SMA200	18.24%	Trades		Volume	469,346	Change	-5.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-24	Initiated	Craig Hallum	Buy	$7
May-20-24	Initiated	Lake Street	Buy	$7
Dec-15-23	Initiated	H.C. Wainwright	Buy	$6.50
Nov-11-20	Upgrade	ROTH Capital	Neutral → Buy	$5 → $7
May-27-20	Initiated	Dougherty & Company	Buy	$8.50
Oct-02-17	Initiated	H.C. Wainwright	Buy	$12

Mar-11-25 01:12PM	Q4 2024 Myomo Inc Earnings Call (Thomson Reuters StreetEvents) +40.77%
03:03AM	Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
Mar-10-25 05:15PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -9.35%
04:05PM	Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million (Business Wire)
Mar-07-25 07:06AM	What To Expect From Myomo Inc (MYO) Q4 2024 Earnings (GuruFocus.com)
04:05PM	Loading…
Mar-03-25 04:05PM	Myomo to Report Fourth Quarter 2024 Financial Results on March 10 (Business Wire) -5.33%
Dec-05-24 07:30AM	Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock (Business Wire) +11.21%
Dec-04-24 04:05PM	Myomo, Inc. Announces Proposed Public Offering of Common Stock (Business Wire)
Nov-07-24 02:22AM	Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives (GuruFocus.com) +20.10%
Nov-06-24 06:00PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.56%
04:05PM	Myomo Reports Record Third Quarter Financial and Operating Results (Business Wire)
Nov-05-24 08:07AM	Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-24 04:05PM	Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage (Business Wire) -6.63%
Oct-30-24 04:05PM	Myomo to Report Third Quarter Financial Results on November 6, 2024 (Business Wire)
Oct-18-24 05:01PM	Rosalind Advisors, Inc. Expands Stake in Myomo Inc (GuruFocus.com)
05:08PM	Loading…
Oct-09-24 05:08PM	Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... (GuruFocus.com)
04:05PM	Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit (Business Wire)
Sep-12-24 08:30AM	Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly (Business Wire)
Sep-05-24 04:15PM	Myomo to Participate in Two Investor Conferences in September (Business Wire)
Aug-06-24 04:05PM	Myomo Reports Second Quarter 2024 Financial Results (Business Wire) -13.33%
Jul-30-24 04:05PM	Myomo to Report Second Quarter Financial Results on August 6, 2024 (Business Wire) -5.53% +7.21%
Jul-27-24 07:40AM	The 3 Best Robotic Exoskeleton Stocks to Buy Now (InvestorPlace)
Jul-26-24 06:05PM	Myomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now (Insider Monkey)
Jul-08-24 08:30AM	Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics (Business Wire) +41.81%
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) +9.71%
Jun-05-24 05:58PM	Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024 (Business Wire)
Jun-01-24 02:42AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-17-24 07:01PM	Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-10-24 04:03PM	Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges (GuruFocus.com) +7.58%
01:01PM	Myomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ... (GuruFocus.com)
01:16PM	Loading…
May-09-24 01:16PM	Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.41%
May-08-24 04:05PM	Myomo Reports First Quarter 2024 Financial Results (Business Wire) +8.56%
May-06-24 01:19PM	Myomo Receives Reimbursements For MyoPros from CMS (MT Newswires)
08:30AM	Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees (Business Wire)
May-01-24 05:21PM	Myomo to Report First Quarter Financial Results on May 8, 2024 (Business Wire) +7.95% +11.05%
Mar-28-24 04:05PM	Myomo Appoints Heather Getz to its Board of Directors (Business Wire) -6.57% -5.50%
Mar-18-24 11:00AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
Mar-08-24 10:15AM	Myomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.38%
Mar-07-24 06:00PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-01-24 08:00AM	CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® (Business Wire) +31.05%
Feb-29-24 04:05PM	Myomo to Report Fourth Quarter Financial Results on March 7, 2024 (Business Wire)
Jan-19-24 04:05PM	Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) -6.33%
Jan-17-24 08:05AM	Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) +7.89%
08:00AM	Myomo Reports Preliminary Fourth Quarter Revenue and Backlog (Business Wire)
Dec-20-23 08:50AM	What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing' (Zacks) -19.21%
Dec-12-23 07:00AM	7 Stock Winners That Are Up 1,000% or More in 2023 (InvestorPlace)
Dec-01-23 10:00AM	Top Penny Stocks for Q4 2023 (Investopedia) +7.42%
Nov-20-23 04:16PM	3 Hot Penny Stocks to Buy in Q4 for Promising Potential (InvestorPlace) +5.88%
Nov-08-23 11:47AM	Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.39%
Nov-07-23 04:05PM	Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations (Business Wire) +6.02%
Nov-06-23 08:30AM	CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting (Business Wire) +21.17%
Nov-02-23 10:08AM	Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category (Business Wire) +8.00%
Oct-31-23 04:05PM	Myomo to Report Third Quarter Financial Results on November 7, 2023 (Business Wire) +10.62%
Aug-29-23 04:05PM	Myomo Announces Closing of $4.4 Million Public Offering (Business Wire) -6.09%
Aug-28-23 12:38PM	Is Myomo (MYO) a Hidden Gem or a Value Trap? A Comprehensive Analysis (GuruFocus.com) +18.69%
Aug-25-23 07:00AM	Myomo Announces Pricing of $4.4 Million Public Offering (Business Wire) -10.13%
Aug-24-23 07:33PM	Myomo Inc (MYO): A Hidden Gem or a Potential Value Trap? (GuruFocus.com) +18.82%
04:15PM	Myomo, Inc. Announces Proposed Public Offering (Business Wire)
04:05PM	Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims (Business Wire)
Aug-21-23 04:05PM	Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement (Business Wire) +10.80% -6.91%
Aug-09-23 05:30PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.00% -7.67%
04:05PM	Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics (Business Wire)
Aug-02-23 04:05PM	Myomo to Report Second Quarter Financial Results on August 9, 2023 (Business Wire) -7.02%
Jul-05-23 10:50AM	Myomo's (MYO) MyoPro Seeks CMS Classification for Medicare Cover (Zacks)
Jul-03-23 08:30AM	Centers for Medicare and Medicaid Services Accepts Myomos Application to Classify the MyoPro® as a Brace (Business Wire) +19.31%
Jun-14-23 04:05PM	Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest (Business Wire) +6.27%
May-22-23 09:55AM	Here's Why Myomo, Inc. (MYO) Is a Great 'Buy the Bottom' Stock Now (Zacks)
May-10-23 06:05PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-23 07:05PM	Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-05-23 07:45AM	Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-03-23 04:05PM	Myomo to Report First Quarter Financial Results on May 10, 2023 (Business Wire) -7.69%
Apr-10-23 08:30AM	Myomo Receives Technology License Fee Payment from China Joint Venture Company (Business Wire) +5.22%
Mar-16-23 05:30AM	SVB Collapse Spurs Finance Executives to Re-Evaluate Cash Strategies (The Wall Street Journal)
Mar-15-23 08:30AM	Myomo Makes NYSE American Section 610(b) Public Announcement (Business Wire)
Mar-14-23 11:11AM	Myomo, Inc. (AMEX:MYO) Q4 2022 Earnings Call Transcript (Insider Monkey) -6.84%
Mar-13-23 09:45AM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Myomo Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Mar-07-23 10:12AM	Myomo to Report Fourth Quarter Financial Results on March 13, 2023 (Business Wire)
Mar-06-23 04:05PM	Myomo To Participate in the 35th Annual Roth Conference (Business Wire) +11.26%
Feb-06-23 04:05PM	MyoPro Approved in Australia by National Disability Insurance Scheme (Business Wire)
Feb-01-23 04:25PM	7 Top Short-Squeeze Candidates to Watch in February (InvestorPlace)
Jan-30-23 04:05PM	Myomo Appoints Yitzchak Jacobovitz to its Board of Directors (Business Wire)
Jan-17-23 04:05PM	Myomo Announces Closing of $6.5 Million Upsized Public Offering (Business Wire)
Jan-12-23 08:30AM	Myomo Announces Pricing of $6.5 Million Upsized Public Offering (Business Wire) -14.99%
Jan-10-23 04:17PM	Myomo Announces Initiative to Reduce Cash Burn (Business Wire) -8.79%
Dec-07-22 05:00PM	Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro (Business Wire) -8.28%
Dec-05-22 08:30AM	Ruling by German Social Court Supports MyoPro Reimbursement by Nations Statutory Health Insurance System (Business Wire)
Nov-21-22 03:04PM	10 Best Robotic Stocks Under $10 (Insider Monkey) -18.64%
Nov-10-22 05:55PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -32.09%
04:05PM	Myomo Reports Third Quarter 2022 Financial Results Featuring Strong Authorizations and Orders and Record Backlog (Business Wire)
Nov-09-22 05:25PM	NuVasive (NUVA) Surpasses Q3 Earnings Estimates (Zacks)
Nov-03-22 04:05PM	Myomo to Report Third Quarter Financial Results on November 10, 2022 (Business Wire)
Oct-05-22 04:30PM	Myomo To Present at the MicroCap Rodeo Presents The Windy City Roundup 2022 (ACCESSWIRE)
Sep-07-22 08:30AM	Myomo to Present at the H.C. Wainwright 24th Annual Global Investment Conference (Business Wire)
Aug-30-22 08:30AM	Myomo Receives Order from the Louis Stokes Cleveland VA Medical Center to Support MyoPro Clinical Trial (Business Wire)
Aug-03-22 06:35PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +13.81% -17.48%
04:05PM	Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions (Business Wire)
Jul-28-22 10:03AM	Maravai LifeSciences Holdings, Inc. (MRVI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-27-22 04:15PM	Myomo to Report Second Quarter Financial Results on August 3, 2022 (Business Wire)

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GUDONIS PAUL R	Chief Executive Officer	Feb 13 '25	Option Exercise	0.05	694	33	1,014,963	Feb 18 04:33 PM
Mitchell Micah	Chief Commercial Officer	Jun 09 '24	Option Exercise	0.00	1,717	0	185,815	Jan 24 05:09 PM
HENRY DAVID A	Chief Financial Officer	Jun 09 '24	Option Exercise	0.00	3,012	0	381,375	Jan 24 05:05 PM
Kovelman Harry	Chief Medical Officer	Jun 09 '24	Option Exercise	0.00	1,235	0	124,549	Jan 24 05:02 PM
GUDONIS PAUL R	Chief Executive Officer	Jun 09 '24	Option Exercise	0.00	6,024	0	1,014,269	Jan 24 04:58 PM
Harry Kovelman	Officer	Nov 04 '24	Proposed Sale	3.70	121	448		Nov 04 03:19 PM
Harry Kovelman	Officer	Oct 03 '24	Proposed Sale	3.86	121	467		Oct 03 12:54 PM
Kovelman Harry	Chief Medical Officer	Sep 05 '24	Sale	3.76	6,700	25,183	123,556	Sep 09 04:04 PM
Kovelman Harry	Chief Medical Officer	Sep 03 '24	Sale	4.01	2,029	8,140	130,395	Sep 05 08:27 AM
Harry Kovelman	Officer	Sep 04 '24	Proposed Sale	3.89	139	541		Sep 04 06:26 PM
Harry Kovelman	Officer	Sep 03 '24	Proposed Sale	4.00	18,500	74,000		Sep 03 05:55 PM
Harry Kovelman	Officer	Aug 05 '24	Proposed Sale	3.96	128	507		Aug 05 11:53 AM
KIRK THOMAS F	Director	May 29 '24	Buy	3.50	50,000	175,000	236,499	May 31 05:43 PM
Kovelman Harry	Chief Medical Officer	May 15 '24	Sale	3.69	35,426	130,839	98,009	May 17 04:57 PM
KIRK THOMAS F	Director	Mar 14 '24	Buy	3.50	50,000	175,000	186,499	Mar 18 07:48 AM

EMBC

Embecta Corp

MYO

Myomo Inc

Upgrade your FINVIZ experience